Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 15,365 | 15,174 | 15,452 | 15,124 | 14,948 |
| Operating Income | -15,365 | -15,174 | -15,452 | -15,124 | -14,948 |
| Other Income | 14 | 7 | 6 | -5 | -2 |
| Pre-tax Income | -15,351 | -15,167 | -15,446 | -15,129 | -14,950 |
| Net Income Continuous | -15,351 | -15,167 | -15,446 | -15,129 | -14,950 |
| Net Income | $-15,351 | $-15,167 | $-15,446 | $-15,129 | $-14,950 |
| EPS Basic Total Ops | -5.60 | -5.60 | -5.60 | -5.40 | -5.40 |
| EPS Basic Continuous Ops | -5.57 | -5.50 | -5.61 | -5.50 | -5.44 |
| EPS Diluted Total Ops | -5.60 | -5.60 | -5.60 | -5.40 | -5.40 |
| EPS Diluted Continuous Ops | -5.57 | -5.50 | -5.61 | -5.50 | -5.44 |
| EBITDA(a) | $-14,704 | $-14,543 | $-14,860 | $-14,582 | $-14,436 |